Number of Shares
8,866.00
Current Holdings Value*
$233,800.00
% of Portfolio
2.46%
Total Estimate Gain
$-94,070.52
% of Total Estimate Gain
-13.22%

Counterpoint Global Portfolio's Royalty Pharma PLC Holding Summary

As of 2024-06-30, Counterpoint Global Portfolio held 8,866.00 shares of Royalty Pharma PLC(RPRX), totaling $233,800.00. This investment constitutes 2.46% of their stock portfolio, and Counterpoint Global Portfolio now holds 0% of the outstanding Royalty Pharma PLC(RPRX) stock.

The initial trade took place in 2020Q2. And since then Counterpoint Global Portfolio has made 10 purchases of RPRX, at an average price of $43.56, for a total of 16,332.00 shares. In addition, there have been 6 sales at an average price of $40.41 for 7,466.00 shares. Based on historical transaction data and RPRX's current price of $35.60, Counterpoint Global Portfolio's estimated gain on his RPRX holdings is $-94,070.52, reflecting a -13.22% gain to date.

Counterpoint Global Portfolio RPRX ($35.60) Holding Chart

Counterpoint Global Portfolio RPRX ($35.60) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1